Recent Funding
Companies
Alethio Therapeutics

Alethio Therapeutics

Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.

Latest funding

$90M Series A · November 5, 2026

Led by RA Capital Management · Source: european-biotechnology.com

Funding history ↓

Website: alethiomics.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Therapeutics.

Stage: Series A.

Based in: Abingdon-on-thames, United Kingdom.

Last round: Nov 5, 2026 · 7 days ago.

Headcount: 1–10 employees.

On Recent Funding since: Nov 6, 2026.

Signals

Website registeredFeb 9, 2021 (5 years old)

Funding rounds

November 5, 2026
Series A · $90M
RRA Capital Management (lead), SSofinnova Partners (lead), CCancer Research Horizons, OOxford Science Enterprises, UUniversity of Oxford
Source: european-biotechnology.com
February 9, 2021
Website created

Founders and team

AM
Adam Mead Founder
BP
Bethan Psaila Founder

LinkedIn
EA
Edward Ainscow Chief Scientific Officer

Investors

Companies like Alethio Therapeutics

GGraph Therapeutics$5M Seed · Jun 2026
SSingleron Biotechnologies$100M Series B+ · Nov 2021
DDalton Bioanalytics
VVan Heron Labs$1.1M Seed · Mar 2024
PPhiTech$2.4M · Apr 2026
EEpinoma

Other companies backed by RA Capital Management

SStar Therapeutics$200M Series B+ · Oct 2026
OOptivolt$32M Series A · Oct 2026
EEstuary Biotherapeutics$103M Series A · Oct 2026
MMMI$125M Series B+ · Oct 2026
AAbcuro$66M Series B+ · Aug 2026
LLifeMine Therapeutics$75M Series B+ · Aug 2026

RA Capital Management portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/alethio-therapeutics (get a free API key).